• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Therapeutic and prophylactic effect of flavonoids in post-COVID-19 therapy.COVID-19 后治疗中类黄酮的治疗和预防作用。
Phytother Res. 2022 May;36(5):2042-2060. doi: 10.1002/ptr.7436. Epub 2022 Mar 18.
2
Flavonoids against the SARS-CoV-2 induced inflammatory storm.黄酮类化合物对抗 SARS-CoV-2 诱导的炎症风暴。
Biomed Pharmacother. 2021 Jun;138:111430. doi: 10.1016/j.biopha.2021.111430. Epub 2021 Feb 25.
3
Natural and Semi-Synthetic Flavonoid Anti-SARS-CoV-2 Agents for the Treatment of Long COVID-19 Disease and Neurodegenerative Disorders of Cognitive Decline.用于治疗新冠长期症状及认知衰退神经退行性疾病的天然和半合成类黄酮抗SARS-CoV-2药物
Front Biosci (Elite Ed). 2022 Oct 9;14(4):27. doi: 10.31083/j.fbe1404027.
4
Nutritional Modulation of Gut Microbiota Alleviates Severe Gastrointestinal Symptoms in a Patient with Post-Acute COVID-19 Syndrome.营养调控肠道菌群可改善急性新冠后综合征患者的严重胃肠道症状。
mBio. 2022 Apr 26;13(2):e0380121. doi: 10.1128/mbio.03801-21. Epub 2022 Mar 7.
5
Pericarditis after SARS-CoV-2 Infection: Another Pebble in the Mosaic of Long COVID?新型冠状病毒感染后的心包炎:长新冠的又一拼图?
Viruses. 2021 Oct 4;13(10):1997. doi: 10.3390/v13101997.
6
Evaluation of the effects of chlorhexidine and several flavonoids as antiviral purposes on SARS-CoV-2 main protease: molecular docking, molecular dynamics simulation studies.评估洗必泰和几种类黄酮作为抗 SARS-CoV-2 主蛋白酶的抗病毒药物的效果:分子对接、分子动力学模拟研究。
J Biomol Struct Dyn. 2022 Oct;40(17):7656-7665. doi: 10.1080/07391102.2021.1900919. Epub 2021 Mar 22.
7
Anti-HIV-drug and phyto-flavonoid combination against SARS-CoV-2: a molecular docking-simulation base assessment.抗 HIV 药物和植物类黄酮联合抗 SARS-CoV-2 的研究:基于分子对接模拟的评估。
J Biomol Struct Dyn. 2022 Sep;40(14):6463-6476. doi: 10.1080/07391102.2021.1885495. Epub 2021 Feb 15.
8
Potential role of flavonoids against SARS-CoV-2 induced diarrhea.黄酮类化合物对抗 SARS-CoV-2 诱导的腹泻的潜在作用。
Trop Biomed. 2021 Sep 1;38(3):360-365. doi: 10.47665/tb.38.3.079.
9
Flavonoids as a therapeutical option for the treatment of thrombotic complications associated with COVID-19.黄酮类化合物作为治疗 COVID-19 相关血栓并发症的治疗选择。
Phytother Res. 2023 Mar;37(3):1092-1114. doi: 10.1002/ptr.7700. Epub 2022 Dec 8.
10
Venous Thromboembolic Disease in COVID-19, Pathophysiology, Therapy and Prophylaxis.COVID-19中的静脉血栓栓塞性疾病:病理生理学、治疗与预防
Int J Mol Sci. 2022 Sep 8;23(18):10372. doi: 10.3390/ijms231810372.

引用本文的文献

1
Role of nutrient supplements in children with post-COVID condition: a retrospective preliminary observation and narrative review.营养补充剂在新冠康复期儿童中的作用:一项回顾性初步观察与叙述性综述。
Ital J Pediatr. 2025 Apr 16;51(1):119. doi: 10.1186/s13052-025-01961-5.
2
Taiwan Chingguan Yihau may improve post-COVID-19 respiratory complications through PI3K/AKT, HIF-1, and TNF signaling pathways revealed by network pharmacology analysis.通过网络药理学分析揭示,台湾清冠一号可能通过PI3K/AKT、HIF-1和TNF信号通路改善新冠后呼吸并发症。
Mol Divers. 2025 Jun;29(3):2305-2321. doi: 10.1007/s11030-024-10993-8. Epub 2024 Oct 9.
3
Therapeutic implications of quercetin and its derived-products in COVID-19 protection and prophylactic.槲皮素及其衍生物在新冠病毒防护和预防方面的治疗意义。
Heliyon. 2024 Apr 30;10(9):e30080. doi: 10.1016/j.heliyon.2024.e30080. eCollection 2024 May 15.
4
Small Molecules for the Treatment of Long-COVID-Related Vascular Damage and Abnormal Blood Clotting: A Patent-Based Appraisal.小分子药物治疗长新冠相关血管损伤和异常血栓形成:基于专利的评估。
Viruses. 2024 Mar 14;16(3):450. doi: 10.3390/v16030450.
5
In Silico Screening of Natural Flavonoids against 3-Chymotrypsin-like Protease of SARS-CoV-2 Using Machine Learning and Molecular Modeling.基于机器学习和分子建模的针对 SARS-CoV-2 3-胰凝乳蛋白酶样蛋白酶的天然类黄酮的计算机筛选。
Molecules. 2023 Dec 10;28(24):8034. doi: 10.3390/molecules28248034.
6
Therapeutic Effect and Safety Evaluation of Naringin on in Mice.柚皮苷对 小鼠的治疗效果和安全性评价。
Int J Mol Sci. 2023 Nov 3;24(21):15940. doi: 10.3390/ijms242115940.
7
Metabolic alterations upon SARS-CoV-2 infection and potential therapeutic targets against coronavirus infection.新冠病毒感染后的代谢改变和针对冠状病毒感染的潜在治疗靶点。
Signal Transduct Target Ther. 2023 Jun 7;8(1):237. doi: 10.1038/s41392-023-01510-8.
8
Natural Flavonoid Derivatives Have Pan-Coronavirus Antiviral Activity.天然黄酮类衍生物具有抗全冠状病毒活性。
Microorganisms. 2023 Jan 25;11(2):314. doi: 10.3390/microorganisms11020314.
9
Anti-Entry Activity of Natural Flavonoids against SARS-CoV-2 by Targeting Spike RBD.天然类黄酮通过靶向刺突 RBD 对 SARS-CoV-2 的抗入侵活性。
Viruses. 2023 Jan 4;15(1):160. doi: 10.3390/v15010160.
10
The Potential of Ameliorating COVID-19 and Sequelae From via Bioinformatics.通过生物信息学改善新冠病毒病及其后遗症的潜力
Bioinform Biol Insights. 2023 Jan 12;17:11779322221149622. doi: 10.1177/11779322221149622. eCollection 2023.

本文引用的文献

1
Group IIA secreted phospholipase A2 is associated with the pathobiology leading to COVID-19 mortality.IIA 组分泌型磷脂酶 A2 与导致 COVID-19 死亡的病理生物学有关。
J Clin Invest. 2021 Oct 1;131(19). doi: 10.1172/JCI149236.
2
Pathophysiology of COVID-19-associated acute kidney injury.COVID-19 相关急性肾损伤的病理生理学。
Nat Rev Nephrol. 2021 Nov;17(11):751-764. doi: 10.1038/s41581-021-00452-0. Epub 2021 Jul 5.
3
Post covid 19 pulmonary fibrosis. Is it real threat?新冠后肺纤维化。这是真实存在的威胁吗?
Indian J Tuberc. 2021 Jul;68(3):330-333. doi: 10.1016/j.ijtb.2020.11.003. Epub 2020 Nov 10.
4
New perspectives on natural flavonoids on COVID-19-induced lung injuries.关于天然类黄酮对 COVID-19 引起的肺部损伤的新观点。
Phytother Res. 2021 Sep;35(9):4988-5006. doi: 10.1002/ptr.7131. Epub 2021 Apr 29.
5
Phyto-pharmacological perspective of Silymarin: A potential prophylactic or therapeutic agent for COVID-19, based on its promising immunomodulatory, anti-coagulant and anti-viral property.水飞蓟宾的植物药理学视角:基于其有前景的免疫调节、抗凝和抗病毒特性,作为 COVID-19 的潜在预防或治疗剂。
Phytother Res. 2021 Aug;35(8):4246-4257. doi: 10.1002/ptr.7084. Epub 2021 Apr 4.
6
SARS-CoV-2 Detection in Fecal Sample from a Patient with Typical Findings of COVID-19 Pneumonia on CT but Negative to Multiple SARS-CoV-2 RT-PCR Tests on Oropharyngeal and Nasopharyngeal Swab Samples.从一名 COVID-19 肺炎 CT 典型表现患者的粪便样本中检测到 SARS-CoV-2,但多次咽拭子和鼻拭子 SARS-CoV-2 RT-PCR 检测均为阴性。
Medicina (Kaunas). 2021 Mar 20;57(3):290. doi: 10.3390/medicina57030290.
7
Flavonoids as potential phytotherapeutics to combat cytokine storm in SARS-CoV-2.类黄酮作为对抗 SARS-CoV-2 细胞因子风暴的潜在植物疗法。
Phytother Res. 2021 Aug;35(8):4258-4283. doi: 10.1002/ptr.7092. Epub 2021 Mar 30.
8
Evaluation of flavonoids as 2019-nCoV cell entry inhibitor through molecular docking and pharmacological analysis.通过分子对接和药理学分析评估黄酮类化合物作为2019新型冠状病毒细胞进入抑制剂的作用
Heliyon. 2021 Mar;7(3):e06515. doi: 10.1016/j.heliyon.2021.e06515. Epub 2021 Mar 14.
9
Gastrointestinal sequelae 90 days after discharge for COVID-19.新冠病毒病出院90天后的胃肠道后遗症
Lancet Gastroenterol Hepatol. 2021 May;6(5):344-346. doi: 10.1016/S2468-1253(21)00076-5. Epub 2021 Mar 10.
10
A Review of Persistent Post-COVID Syndrome (PPCS).对持续性 COVID-19 后综合征(PPCS)的综述。
Clin Rev Allergy Immunol. 2023 Feb;64(1):66-74. doi: 10.1007/s12016-021-08848-3. Epub 2021 Feb 20.

COVID-19 后治疗中类黄酮的治疗和预防作用。

Therapeutic and prophylactic effect of flavonoids in post-COVID-19 therapy.

机构信息

Department of Pharmacology, Medical Faculty of University of Pavol Jozef Šafárik in Košice, Košice, Slovak Republic.

Institute of Parasitology, Slovak Academy of Science, Košice, Slovak Republic.

出版信息

Phytother Res. 2022 May;36(5):2042-2060. doi: 10.1002/ptr.7436. Epub 2022 Mar 18.

DOI:10.1002/ptr.7436
PMID:35302260
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9111001/
Abstract

The high incidence of post-covid symptoms in humans confirms the need for effective treatment. Due to long-term complications across several disciplines, special treatment programs emerge for affected patients, emphasizing multidisciplinary care. For these reasons, we decided to look at current knowledge about possible long-term complications of COVID-19 disease and then present the effect of flavonoids, which could help alleviate or eliminate complications in humans after overcoming the COVID-19 infection. Based on articles published from 2003 to 2021, we summarize the flavonoids-based molecular mechanisms associated with the post-COVID-19 syndrome and simultaneously provide a complex view regarding their prophylactic and therapeutic potential. Review clearly sorts out the outcome of post-COVID-19 syndrome according particular body systems. The conclusion is that flavonoids play an important role in prevention of many diseases. We suggest that flavonoids as critical nutritional supplements, are suitable for the alleviation and shortening of the period associated with the post-COVID-19 syndrome. The most promising flavonoid with noteworthy therapeutic and prophylactic effect appears to be quercetin.

摘要

人类中新冠病毒后遗症的高发病率证实了有效治疗的必要性。由于涉及多个学科的长期并发症,出现了针对受影响患者的特殊治疗方案,强调多学科护理。基于这些原因,我们决定研究目前关于 COVID-19 疾病可能的长期并发症的知识,然后介绍类黄酮的作用,类黄酮可能有助于减轻或消除人类在克服 COVID-19 感染后的并发症。根据 2003 年至 2021 年发表的文章,我们总结了与新冠后综合征相关的基于类黄酮的分子机制,并同时提供了关于其预防和治疗潜力的综合观点。综述清楚地按照特定的身体系统对新冠后综合征的结果进行分类。结论是,类黄酮在预防许多疾病方面发挥着重要作用。我们建议将类黄酮作为重要的营养补充剂,适用于缓解和缩短与新冠后综合征相关的时期。最有前途的具有显著治疗和预防作用的类黄酮似乎是槲皮素。